Kinghall Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China Digest: Drug developer Hope nets $56m; biotech firm Yikon raises $39m Source: Laurynas Mereckas/Unsplash May 6, 2021 Chinese innovative drug developer Hope Medicine has secured $56 million in a funding round led by investment firms Qiming Venture Partners and Grand Flight Investment, while biotech firm Yikon Genomics has raised 250 million yuan ($38.6 million). Qiming, Grand Flight lead $56m round in drug maker Hope Chinese drug developer Hope Medicine has secured $56 million in a Series B round of financing jointly led by investment firms Qiming Venture Partners and Grand Flight Invest...

Published: Mar 05, 2021 By Mark Terry Boston-based ABclonal Biotechnology acquiredcontract research organization (CRO) Yurogen Biosystems, headquartered in nearby Worcester, Massachusetts. Yurogen focuses on producing antibodies and antibody-based products for its clients. Its technology platform is a monoclonal antibody discovery program using single-B-cell-based SMab. This technology platform allows for high-throughput development of high-affinity, high-specificity monoclonal antibodies. No financial details were disclosed. Late in February, ABclonal, which calls itself a global li...

/PRNewswire/ -- ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by...

GL Ventures leads $92m Series D in Chinese molecular diagnostics specialist Coyote Coyote Bioscience. Visuals from the company website Premium GL Ventures, the venture capital (VC) arm of Hillhouse Capital, has led a Series D funding of nearly 600 million yuan ($91.6 million) in Coyote Bioscience, a Chinese molecular diagnostics firm that specialises in point-of-care testing (POCT). Continue reading this story with a subscription to DealStreetAsia. Contact us for corporate subscriptions at subs@dealstreetasia.com. Sign up for our newsletter - The Daily Brie...

streetAsia's premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. SUBSCRIBE NOW Singapore Reporter/s In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of f...